EyeDose: An open-source tool for using published Monte Carlo results to estimate the radiation dose delivered to the tumor and critical ocular structures for 125I Collaborative Ocular Melanoma Study eye plaques
- PMID: 33187821
- DOI: 10.1016/j.brachy.2020.09.007
EyeDose: An open-source tool for using published Monte Carlo results to estimate the radiation dose delivered to the tumor and critical ocular structures for 125I Collaborative Ocular Melanoma Study eye plaques
Abstract
Purpose: Radiation side effects and visual outcome for uveal melanoma patients managed with plaque radiotherapy are dependent on the radiation dose administered to the tumor and nearby healthy tissues. We have developed an open-source software tool, EyeDose, to simplify and standardize tumor and critical structure dose reporting for Collaborative Ocular Melanoma Study eye plaques.
Methods and materials: EyeDose is a MATLAB-based program that calculates point dose and volume dose metrics for standard models of the tumor and critical ocular structures. It uses published three-dimensional dose distributions for eye plaques, calculated with Monte Carlo methods, which are oriented with respect to the eye using the tumor's position on a fundus diagram. A standard model for the ocular structures was created using published measurements and patient CT scans. EyeDose reports radiation statistics for the fovea, optic disc, lens, lacrimal gland, retina, and tumor. The dosimetric margin for implant placement uncertainty is also calculated.
Results: EyeDose calculations were validated against previously published Monte Carlo results for eight different tumor positions, including the dose to the fovea, optic disc, lacrimal gland, lens, and along the central axis. EyeDose accepts a spreadsheet input for rapidly processing large retrospective patient data sets, with an average run time of <40 s per patient. EyeDose is published as an open-source tool for easy adaptation at different institutions.
Conclusions: EyeDose calculates radiation statistics for Collaborative Ocular Melanoma Study eye plaque patients with Monte Carlo accuracy and without a treatment planning system. EyeDose streamlines data collection for large retrospective studies and can also be used prospectively to assess plaque applicability.
Keywords: COMS; Dosimetry; Eye plaque; EyeDose; Monte Carlo; Treatment planning system.
Copyright © 2021 American Brachytherapy Society. Published by Elsevier Inc. All rights reserved.
Similar articles
-
A practical approach to estimating optic disc dose and macula dose without treatment planning in ocular brachytherapy using 125I COMS plaques.Radiat Oncol. 2018 Nov 13;13(1):221. doi: 10.1186/s13014-018-1166-z. Radiat Oncol. 2018. PMID: 30424782 Free PMC article.
-
Dosimetry of (125)I and (103)Pd COMS eye plaques for intraocular tumors: report of Task Group 129 by the AAPM and ABS.Med Phys. 2012 Oct;39(10):6161-84. doi: 10.1118/1.4749933. Med Phys. 2012. PMID: 23039655
-
Dosimetric comparison of circular Eye Physics and Collaborative Ocular Melanoma Study plaques to treat uveal melanoma.Brachytherapy. 2019 May-Jun;18(3):404-410. doi: 10.1016/j.brachy.2019.01.005. Epub 2019 Feb 20. Brachytherapy. 2019. PMID: 30797699
-
Ocular malignancies treated with iodine-125 low dose rate (LDR) brachytherapy at a single high-volume institution: A retrospective review.Med Dosim. 2022 Autumn;47(3):273-279. doi: 10.1016/j.meddos.2022.04.006. Epub 2022 May 26. Med Dosim. 2022. PMID: 35644778 Review.
-
Wolfram-silicone implants as effective radiation shielding for ocular brachytherapy: dosimetric features and in vivo animal study on biocompatibility.Can J Ophthalmol. 2024 Oct;59(5):e515-e524. doi: 10.1016/j.jcjo.2024.04.011. Epub 2024 May 28. Can J Ophthalmol. 2024. PMID: 38815956 Review.
Cited by
-
Central subfield thickness predicts visual acuity outcomes in plaque-irradiated eyes with choroidal melanoma.Graefes Arch Clin Exp Ophthalmol. 2024 Apr;262(4):1305-1320. doi: 10.1007/s00417-023-06313-9. Epub 2023 Nov 11. Graefes Arch Clin Exp Ophthalmol. 2024. PMID: 37950755
-
Sensitivity of contributing factors to heterogeneity corrections in dosimetry of ocular brachytherapy using iodine-125 COMS plaques.J Contemp Brachytherapy. 2024 Oct;16(5):371-382. doi: 10.5114/jcb.2024.144232. Epub 2024 Oct 18. J Contemp Brachytherapy. 2024. PMID: 39719954 Free PMC article.
-
Current and Emerging Radiotherapy Options for Uveal Melanoma.Cancers (Basel). 2024 Mar 6;16(5):1074. doi: 10.3390/cancers16051074. Cancers (Basel). 2024. PMID: 38473430 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical